Chemoinformaics analysis of METHYL-(3S,5S)-5-HYDROXY-3-(BETA-D-GLUCOPYRANOSYLOXY)-HEXANOATE
| Molecular Weight | 324.326 | nRot | 7 |
| Heavy Atom Molecular Weight | 300.134 | nRig | 7 |
| Exact Molecular Weight | 324.142 | nRing | 1 |
| Solubility: LogS | -0.157 | nHRing | 1 |
| Solubility: LogP | -1.865 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 46 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 22 | No. of Aromatic Carbocycles | 0 |
| nHetero | 9 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 13 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 9 | No. of Arom Bond | 0 |
| nHA | 9 | APOL | 44.931 |
| nHD | 5 | BPOL | 30.153 |
| QED | 0.321 |
| Synth | 4.1 |
| Natural Product Likeliness | 1.964 |
| NR-PPAR-gamma | 0.016 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.746 |
| HIA | 0.919 |
| CACO-2 | -5.701 |
| MDCK | 0.000399905 |
| BBB | 0.453 |
| PPB | 0.136334 |
| VDSS | 0.352 |
| FU | 0.716431 |
| CYP1A2-inh | 0.003 |
| CYP1A2-sub | 0.075 |
| CYP2c19-inh | 0.009 |
| CYP2c19-sub | 0.645 |
| CYP2c9-inh | 0 |
| CYP2c9-sub | 0.224 |
| CYP2d6-inh | 0.002 |
| CYP2d6-sub | 0.122 |
| CYP3a4-inh | 0.009 |
| CYP3a4-sub | 0.034 |
| CL | 1.897 |
| T12 | 0.741 |
| hERG | 0.018 |
| Ames | 0.257 |
| ROA | 0.018 |
| SkinSen | 0.024 |
| Carcinogencity | 0.075 |
| EI | 0.011 |
| Respiratory | 0.02 |
| NR-Aromatase | 0.005 |
| Antiviral | Yes |
| Prediction | 0.776005 |